BetterLife Pharma (NPAU) Ratios

0 Followers

BetterLife Pharma Ratios

DE:NPAU's free cash flow for Q4 2026 was C$0.00. For the 2026 fiscal year, DE:NPAU's free cash flow was decreased by C$ and operating cash flow was C$0.00. See a summary of the company’s cash flow.

Ratios	TTM	Apr 26	Apr 25	Apr 24	Apr 23
Liquidity Ratios
Current Ratio	―	0.03	0.03	0.05	0.01
Quick Ratio	―	0.03	0.03	0.05	0.01
Cash Ratio	―	<0.01	<0.01	<0.01	<0.01
Solvency Ratio	―	-0.22	0.16	-0.36	-1.18
Operating Cash Flow Ratio	―	-0.09	-0.27	-0.36	-0.21
Short-Term Operating Cash Flow Coverage	―	-0.71	-2.32	0.00	-2.01
Net Current Asset Value	C$ ―	C$ -6.49M	C$ -7.36M	C$ -7.70M	C$ -7.53M
Leverage Ratios
Debt-to-Assets Ratio	―	4.12	5.79	4.52	15.89
Debt-to-Equity Ratio	―	-0.09	-0.12	-0.14	-0.11
Debt-to-Capital Ratio	―	-0.10	-0.14	-0.16	-0.12
Long-Term Debt-to-Capital Ratio	―	>-0.01	>-0.01	-0.03	-0.04
Financial Leverage Ratio	―	-0.02	-0.02	-0.03	>-0.01
Debt Service Coverage Ratio	―	-1.63	-2.77	-62.70	-11.35
Interest Coverage Ratio	―	-7.80	-15.65	-63.66	-140.83
Debt to Market Cap	―	0.12	0.06	0.03	0.09
Interest Debt Per Share	―	<0.01	0.01	0.01	0.01
Net Debt to EBITDA	―	-0.49	-0.39	-0.45	-0.13
Profitability Margins
Gross Profit Margin	―	0.00%	0.00%	0.00%	0.00%
EBIT Margin	―	0.00%	0.00%	0.00%	0.00%
EBITDA Margin	―	0.00%	0.00%	0.00%	0.00%
Operating Profit Margin	―	0.00%	0.00%	0.00%	0.00%
Pretax Profit Margin	―	0.00%	0.00%	0.00%	0.00%
Net Profit Margin	―	0.00%	0.00%	0.00%	0.00%
Continuous Operations Profit Margin	―	0.00%	0.00%	0.00%	0.00%
Net Income Per EBT	―	98.85%	97.19%	99.67%	96.20%
EBT Per EBIT	―	83.65%	72.44%	89.45%	99.07%
Return on Assets (ROA)	―	-680.07%	-1564.83%	-889.63%	-12065.52%
Return on Equity (ROE)	―	15.28%	32.97%	26.73%	84.04%
Return on Capital Employed (ROCE)	―	28.00%	68.37%	49.83%	133.76%
Return on Invested Capital (ROIC)	―	32.40%	82.51%	54.44%	167.19%
Return on Tangible Assets	―	-680.07%	-1564.83%	-889.63%	-12065.52%
Earnings Yield	―	-20.50%	-21.86%	-29.37%	-69.44%
Efficiency Ratios
Receivables Turnover	―	0.00	0.00	0.00	0.00
Payables Turnover	―	0.00	0.00	0.00	<0.01
Inventory Turnover	―	0.00	0.00	0.00	0.00
Fixed Asset Turnover	―	0.00	0.00	0.00	0.00
Asset Turnover	―	0.00	0.00	0.00	0.00
Working Capital Turnover Ratio	―	0.00	0.00	0.00	0.00
Cash Conversion Cycle	―	0.00	0.00	0.00	-77.96K
Days of Sales Outstanding	―	0.00	0.00	0.00	0.00
Days of Inventory Outstanding	―	0.00	0.00	0.00	0.00
Days of Payables Outstanding	―	0.00	0.00	0.00	77.96K
Operating Cycle	―	0.00	0.00	0.00	0.00
Cash Flow Ratios
Operating Cash Flow Per Share	―	>-0.01	-0.02	-0.02	-0.02
Free Cash Flow Per Share	―	>-0.01	-0.02	-0.02	-0.02
CapEx Per Share	―	<0.01	0.00	0.00	0.00
Free Cash Flow to Operating Cash Flow	―	1.00	1.00	1.00	1.00
Dividend Paid and CapEx Coverage Ratio	―	-125.09K	0.00	0.00	0.00
Capital Expenditure Coverage Ratio	―	-125.09K	0.00	0.00	0.00
Operating Cash Flow Coverage Ratio	―	-0.69	-1.55	-1.68	-1.27
Operating Cash Flow to Sales Ratio	―	0.00	0.00	0.00	0.00
Free Cash Flow Yield	―	-8.57%	-12.56%	-25.14%	-11.58%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-4.90	-4.58	-3.40	-1.44
Price-to-Sales (P/S) Ratio	―	0.00	0.00	0.00	0.00
Price-to-Book (P/B) Ratio	―	-0.75	-1.51	-0.91	-1.21
Price-to-Free Cash Flow (P/FCF) Ratio	―	-11.66	-7.96	-3.98	-8.64
Price-to-Operating Cash Flow Ratio	―	-11.66	-7.96	-3.98	-8.64
Price-to-Earnings Growth (PEG) Ratio	―	0.08	-0.60	0.05	0.04
Price-to-Fair Value	―	-0.75	-1.51	-0.91	-1.21
Enterprise Value Multiple	―	-4.53	-5.27	-3.53	-1.53
Enterprise Value	―	8.19M	17.40M	11.27M	14.16M
EV to EBITDA	―	-4.53	-5.27	-3.53	-1.53
EV to Sales	―	0.00	0.00	0.00	0.00
EV to Free Cash Flow	―	-13.09	-8.60	-4.56	-9.42
EV to Operating Cash Flow	―	-13.09	-8.60	-4.56	-9.42
Tangible Book Value Per Share	―	-0.04	-0.06	-0.07	-0.09
Shareholders’ Equity Per Share	―	-0.07	-0.09	-0.10	-0.12
Tax and Other Ratios
Effective Tax Rate	―	0.00	0.00	0.00	0.00
Revenue Per Share	―	0.00	0.00	0.00	0.00
Net Income Per Share	―	-0.01	-0.03	-0.03	-0.10
Tax Burden	―	0.99	0.97	1.00	0.96
Interest Burden	―	0.84	0.77	0.90	1.01
Research & Development to Revenue	―	0.00	0.00	0.00	0.00
SG&A to Revenue	―	0.00	0.00	0.00	0.00
Stock-Based Compensation to Revenue	―	0.00	0.00	0.00	0.00
Income Quality	―	0.41	0.56	0.86	0.16

Currency in CAD